• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人状况与老年人药物不良反应风险:综述。

Geriatric conditions and the risk of adverse drug reactions in older adults: a review.

机构信息

Scientific Direction, Italian National Research Center on Aging (INRCA), Ancona, Italy.

出版信息

Drug Saf. 2012 Jan;35 Suppl 1:55-61. doi: 10.1007/BF03319103.

DOI:10.1007/BF03319103
PMID:23446786
Abstract

While polypathology and polypharmacy are well known risk factors for adverse drug reactions (ADRs), the association between geriatric conditions (GCs), i.e. a set of clinical and functional problems partly constitutive of and partly related to frailty, and ADRs is suspected but has not been fully elucidated. Several studies have assessed the relationship between single GCs and ADRs, but only a few studies have systematically evaluated the relationship between the whole spectrum of GCs and ADRs. The mechanism by which select GCs increase the risk of developing ADRs during a hospital stay might simply reflect a sort of general predictability of physical disability with respect to adverse outcomes. However, GCs pertaining to the physical dimension of frailty are generally associated with relevant changes in pharmacokinetics and pharmacodynamics of select drugs. While current evidence could not be considered either unequivocal or conclusive, select GCs, e.g. a history of falls and loss of independence in the activities of daily living, seem to define a condition of particular vulnerability of elderly patients to ADRs.

摘要

虽然多病理学和多药物治疗是已知的药物不良反应 (ADR) 的危险因素,但老年病学状况 (GCs) 与 ADR 之间的关联,即一组部分构成和部分与虚弱相关的临床和功能问题,被怀疑但尚未完全阐明。有几项研究评估了单一 GCs 与 ADRs 之间的关系,但只有少数研究系统地评估了整个 GCs 谱与 ADRs 之间的关系。在住院期间,某些 GCs 增加发生 ADRs 的风险的机制可能只是反映了身体残疾对不良结果的某种普遍可预测性。然而,与虚弱的身体维度相关的 GCs 通常与特定药物的药代动力学和药效学的相关变化相关。虽然目前的证据不能被认为是明确或结论性的,但某些 GCs,例如跌倒史和日常生活活动丧失独立性,似乎定义了老年患者对 ADRs 特别脆弱的一种情况。

相似文献

1
Geriatric conditions and the risk of adverse drug reactions in older adults: a review.老年人状况与老年人药物不良反应风险:综述。
Drug Saf. 2012 Jan;35 Suppl 1:55-61. doi: 10.1007/BF03319103.
2
Do geriatric conditions increase risk of adverse drug reactions in ambulatory elders? Results from the VA GEM Drug Study.老年人的健康状况是否会增加门诊老年人发生药物不良反应的风险?VA GEM 药物研究的结果。
J Gerontol A Biol Sci Med Sci. 2011 Apr;66(4):444-51. doi: 10.1093/gerona/glq236. Epub 2011 Feb 14.
3
Adverse drug reactions in special populations - the elderly.特殊人群中的药物不良反应——老年人
Br J Clin Pharmacol. 2015 Oct;80(4):796-807. doi: 10.1111/bcp.12596. Epub 2015 May 22.
4
Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.肿瘤人群中的药物不良反应:发生率、可预测性和可预防。
Oncologist. 2019 Sep;24(9):e968-e977. doi: 10.1634/theoncologist.2018-0476. Epub 2019 Mar 4.
5
Adverse drug reactions in older adults: a narrative review of the literature.老年人的药物不良反应:文献综述
Eur Geriatr Med. 2021 Jun;12(3):463-473. doi: 10.1007/s41999-021-00481-9. Epub 2021 Mar 18.
6
Adverse drug reactions and polypharmacy in the elderly in general practice.全科医疗中老年人的药物不良反应与多重用药
Eur J Clin Pharmacol. 1999 Sep;55(7):533-6. doi: 10.1007/s002280050669.
7
A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting.急性护理环境中老年人药物不良反应患病率及危险因素的系统评价。
Clin Interv Aging. 2014 Dec 1;9:2079-86. doi: 10.2147/CIA.S71178. eCollection 2014.
8
Family conferences and shared prioritisation to improve patient safety in the frail elderly (COFRAIL): study protocol of a cluster randomised intervention trial in primary care.家庭会议和共同优先级排序以改善虚弱老年人的患者安全(COFRAIL):初级保健中群组随机干预试验的研究方案。
Trials. 2020 Mar 20;21(1):285. doi: 10.1186/s13063-020-4182-x.
9
The effect of SENATOR (Software ENgine for the Assessment and optimisation of drug and non-drug Therapy in Older peRsons) on incident adverse drug reactions (ADRs) in an older hospital cohort - Trial Protocol.SENATOR(老年人药物和非药物治疗评估与优化软件)对老年住院患者新发药物不良反应(ADR)的影响 - 试验方案。
BMC Geriatr. 2019 Feb 13;19(1):40. doi: 10.1186/s12877-019-1047-9.
10
Medication prescribing in frail older people.老年人虚弱者的药物处方。
Eur J Clin Pharmacol. 2013 Mar;69(3):319-26. doi: 10.1007/s00228-012-1387-2. Epub 2012 Sep 11.

引用本文的文献

1
The influence of age, gender and pharmacogenetic profiles on the perspective on medicines in the German EMPAR study.德国 EMPAR 研究中年龄、性别和药物遗传学特征对药物认知的影响。
PLoS One. 2024 Oct 10;19(10):e0311267. doi: 10.1371/journal.pone.0311267. eCollection 2024.
2
Deprescribing interventions in older adults: An overview of systematic reviews.老年患者减药干预措施的系统评价概述。
PLoS One. 2024 Jun 17;19(6):e0305215. doi: 10.1371/journal.pone.0305215. eCollection 2024.
3
Patients' Characterization, Pattern of Medication Use, and Factors Associated with Polypharmacy: A Cross-Sectional Study Focused on Eight Units of the Portuguese National Network for Long-Term Integrated Care.

本文引用的文献

1
Polypharmacy, adverse drug reactions, and geriatric syndromes.多种药物治疗、药物不良反应和老年综合征。
Clin Geriatr Med. 2012 May;28(2):173-86. doi: 10.1016/j.cger.2012.01.002.
2
Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response.炎症介导的药物转运体表达/活性变化:对治疗药物反应的影响。
Expert Rev Clin Pharmacol. 2012 Jan;5(1):69-89. doi: 10.1586/ecp.11.66.
3
Geriatric conditions and adverse drug reactions in elderly hospitalized patients.老年住院患者的老年病状况和药物不良反应。
患者特征、用药模式及与多重用药相关的因素:一项针对葡萄牙国家长期综合护理网络八个单位的横断面研究
Healthcare (Basel). 2023 Dec 26;12(1):57. doi: 10.3390/healthcare12010057.
4
Insight into Risk Factors, Pharmacogenetics/Genomics, and Management of Adverse Drug Reactions in Elderly: A Narrative Review.老年人药物不良反应的风险因素、药物遗传学/基因组学及管理的深入探讨:一项叙述性综述
Pharmaceuticals (Basel). 2023 Nov 1;16(11):1542. doi: 10.3390/ph16111542.
5
Assessing real-world safety concerns of Sacituzumab govitecan: a disproportionality analysis using spontaneous reports in the FDA adverse event reporting system.评估戈沙妥珠单抗的真实世界安全性问题:使用美国食品药品监督管理局不良事件报告系统中的自发报告进行的不成比例分析。
Front Oncol. 2023 Oct 6;13:1276976. doi: 10.3389/fonc.2023.1276976. eCollection 2023.
6
Adverse drug reactions in older adults: a narrative review of the literature.老年人的药物不良反应:文献综述
Eur Geriatr Med. 2021 Jun;12(3):463-473. doi: 10.1007/s41999-021-00481-9. Epub 2021 Mar 18.
7
Anti-Cholinergic Drug Burden Among Ambulatory Elderly Patients in a Nigerian Tertiary Healthcare Facility.尼日利亚一家三级医疗机构中门诊老年患者的抗胆碱能药物负担
Front Pharmacol. 2021 Jan 29;12:580152. doi: 10.3389/fphar.2021.580152. eCollection 2021.
8
An Algorithm for Comprehensive Medication Management in Nursing Homes: Results of the AMBER Project.养老院综合药物管理算法:琥珀项目的结果。
Drug Saf. 2021 Mar;44(3):313-325. doi: 10.1007/s40264-020-01016-0. Epub 2020 Oct 31.
9
New harmonized considerations on the evaluation instruments for baseline characterization of frailty in the European Union.欧盟关于衰弱基线特征评估工具的新统一考量
Br J Clin Pharmacol. 2019 Jul 5;86(10):2017-9. doi: 10.1111/bcp.14044.
10
Factors associated with adverse drug reaction occurrence and prognosis, and their economic impacts in older inpatients in Taiwan: a nested case-control study.与台湾老年住院患者药物不良反应发生和预后相关的因素及其经济影响:一项嵌套病例对照研究。
BMJ Open. 2019 May 10;9(5):e026771. doi: 10.1136/bmjopen-2018-026771.
J Am Med Dir Assoc. 2012 Feb;13(2):96-9. doi: 10.1016/j.jamda.2011.04.006. Epub 2011 May 31.
4
Associations between drug burden index and falls in older people in residential aged care.药物负担指数与居住在养老院的老年人跌倒之间的关联。
J Am Geriatr Soc. 2011 May;59(5):875-80. doi: 10.1111/j.1532-5415.2011.03386.x. Epub 2011 May 3.
5
Pharmacogenetics in geriatric medicine: challenges and opportunities for clinical practice.老年医学中的药物遗传学:临床实践的挑战与机遇。
Curr Drug Metab. 2011 Sep;12(7):621-34. doi: 10.2174/138920011796504545.
6
Paying attention to pharmacokinetic and pharmacodynamic mechanisms to progress in the area of anticholinergic use in geriatric patients.关注药代动力学和药效学机制,推进老年患者抗胆碱能药物使用领域的发展。
Curr Drug Metab. 2011 Sep;12(7):635-46. doi: 10.2174/138920011796504518.
7
Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems.年龄相关的药效学变化:重点关注作用于中枢神经系统和心血管系统的药物。
Curr Drug Metab. 2011 Sep;12(7):611-20. doi: 10.2174/138920011796504473.
8
The risk of adverse drug reactions in older patients: beyond drug metabolism.老年患者药物不良反应的风险:超越药物代谢。
Curr Drug Metab. 2011 Sep;12(7):647-51. doi: 10.2174/138920011796504563.
9
Age-related changes in pharmacokinetics.与年龄相关的药代动力学变化。
Curr Drug Metab. 2011 Sep;12(7):601-10. doi: 10.2174/138920011796504527.
10
Geriatric conditions, medication use, and risk of adverse drug events in a predominantly male, older veteran population.老年病状况、药物使用与主要为男性的老年退伍军人人群中不良药物事件的风险。
J Am Geriatr Soc. 2011 Apr;59(4):615-21. doi: 10.1111/j.1532-5415.2011.03331.x. Epub 2011 Mar 15.